Nautilus Biotechnology Launches “First Access Challenge”
SEATTLE, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the launch of the First Access Challenge, a research competition for high-impact work in single-molecule proteomics.
- SEATTLE, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the launch of the First Access Challenge, a research competition for high-impact work in single-molecule proteomics.
- Scientists of all backgrounds are invited to submit proposals and gain early access to Nautilus Proteome Analysis Platform.
- Nautilus single-molecule, large-scale platform uses Protein Identification by Short-epitope Mapping (PrISM) with an aim of easily and sensitively measuring billions of intact proteins.
- Nautilus mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine.